Lazard, Inc. filings document the regulatory record for a financial advisory and asset management company listed on the NYSE under LAZ. Form 8-K reports furnish quarterly and annual results, Regulation FD strategy updates, material agreements, executive officer changes, compensation arrangements, and other material-event disclosures tied to the firm’s advisory and asset management businesses.
Proxy materials cover board elections, governance practices, executive compensation and shareholder voting matters. The company’s risk-factor disclosures address conditions in global and regional financial markets, M&A activity, assets under management, liquidity, third-party exposures and competition, alongside capital-structure and reporting matters.
Dmitry Shevelenko, a Lazard, Inc. director, was awarded 2,126 Deferred Stock Units (DSUs) under the companys 2018 Incentive Compensation Plan on 09/16/2025. The DSUs are part of the Non-Executive Director Compensation arrangement and will convert one-for-one into common stock only after the reporting person resigns or otherwise ceases to be a member of Lazards Board. The Form 4 covering this award was signed by Dmitry Shevelenko via power of attorney on 09/18/2025 and lists his business address at Lazard, Inc., 30 Rockefeller Plaza, New York, NY 10112.
Lazard, Inc. (LAZ) reporting person Peter R. Orszag, CEO & Chairman and director, exchanged a prior grant of 64,949 RSUs for 64,949 shares of common stock on 09/15/2025. On that date 19,485 shares were sold back to the company to cover estimated taxes at an NYSE closing price of $55.59. On 09/16/2025 an additional 32,475 shares were sold in transactions effected under a Rule 10b5-1 trading plan at a weighted average price of $54.09. Following these transactions, the reporting person beneficially owned 183,274 shares.
Lazard, Inc. (LAZ) submitted a Form 144 reporting a proposed sale of 32,475 common shares through Fidelity Brokerage Services on the NYSE, with an approximate aggregate market value of $1,762,743. The filer states the shares were acquired on 09/15/2025 by restricted stock vesting from the issuer and were paid as compensation. The filing lists the approximate date of sale as 09/16/2025 and reports 112,766,091 shares outstanding for the issuer. The filer indicates no securities sold in the past three months and includes the standard representation that no undisclosed material adverse information is known.
Evan L. Russo, an officer (CEO of Asset Management) of Lazard, Inc. (LAZ), reported three transactions in September 2025 affecting his beneficial ownership of Lazard common stock. On 09/09/2025 he donated 15,000 shares as a bona fide gift to a charitable donor-advised fund. On 09/10/2025 he sold 25,000 shares at a weighted average price of $55.7064. On 09/11/2025 he sold 50,000 shares at a weighted average price of $56.952. After these transactions he directly beneficially owned 227,915 shares, excluding 358,299 restricted participation units and 1,000,000 stock price performance-based restricted participation units that he directly beneficially owns.
Michael Gathy, Chief Accounting Officer of Lazard, Inc. (LAZ), reported a sale of 617 shares of Lazard common stock on 09/10/2025 at a price of $55.37 per share. After this transaction the filing reports 0 shares of common stock beneficially owned directly, with a disclosure that 9,258 restricted stock units (RSUs) are excluded from the reported count and remain directly or indirectly beneficially owned by the reporting person. The Form 4 was signed under power of attorney on 09/11/2025. The filing reflects a routine insider disposition rather than any additional transaction types or derivative activity.
Dmitry Shevelenko, a director of Lazard, Inc. (LAZ), filed an initial Form 3 reporting that he does not beneficially own any Lazard securities. The event date listed is 09/02/2025 and the form was signed under power of attorney on 09/11/2025. The filing identifies Shevelenko's business address at Lazard, Inc., 30 Rockefeller Plaza, New York, NY 10112. This Form 3 provides a formal disclosure of the reporting person's status with no securities reported.
Lazard, Inc. (LAZ) Form 144 filing reports proposed and recent sales of common stock by an insider. The filer plans to sell 50,000 shares through Fidelity Brokerage Services with an approximate aggregate market value of $2,847,600.20, representing part of 112,766,091 shares outstanding. The securities were acquired on 03/13/2025 via restricted stock vesting and were paid as compensation. The filing shows a prior sale by the same person of 25,000 shares on 09/10/2025 for gross proceeds of $1,392,661.22. The filer certifies no undisclosed material adverse information.
Lazard, Inc. (LAZ) filed a Form 144 reporting a proposed sale of 25,000 common shares held by a person who acquired the shares on 03/13/2025 through restricted stock vesting as compensation. The proposed sale lists Fidelity Brokerage Services LLC as the broker, an approximate aggregate market value of $1,392,661.22, and the issuer's outstanding shares shown as 112,766,091. The filing indicates an approximate sale date of 09/10/2025 and states there were no securities sold by the filer in the past three months. The filer certifies no undisclosed material adverse information.
Form 144 Notice for Lazard, Inc. (LAZ) reports a proposed sale of 617 shares of common stock through Fidelity Brokerage Services on the NYSE with an aggregate market value of $34,163.29. The filing lists total shares outstanding of 112,766,091. The securities to be sold were acquired mainly through restricted stock vesting: 612 shares vested on 03/03/2025 and 5 shares vested on 02/23/2024, both recorded as compensation. The filer indicates no securities sold in the past three months and includes the standard representation that they are unaware of undisclosed material adverse information about the issuer.
Lazard, Inc. filed a Form 8-K to note that on September 10, 2025 it posted on its website a letter updating its vision and long-term growth strategy for “Lazard 2030.” The disclosure is furnished under Regulation FD, meaning it is intended to provide broad, simultaneous access to this strategic information.
The company explains that the letter and this report contain forward-looking statements about its long-term strategy, business plans and projected financial and operational performance, including initiatives related to artificial intelligence. Lazard highlights numerous risk factors that could cause actual results to differ, such as global economic and market conditions, levels of M&A activity, changes in assets under management, liquidity, competitive pressures on compensation, tax law changes, and the impact of investments in technology and data science capabilities.